Rickets Due to Hereditary Abnormalities of Vitamin D Synthesis or Action

Pediatric Bone: Biology & Diseases

Volumn , Issue , 2003, Pages 583-602

  Portale, Anthony A ^a   Miller, Walter L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547803312     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012286551-0/50026-9     Document Type: Chapter

References (125)

1. Feldman D., Malloy P.J., Gross C. Vitamin D: Metabolism and action. Osteoporosis 1996, 205-235. Academic Press, Amsterdam. R. Marcus (Ed.).
2. 3 production by human keratinocytes. J.Clin. Invest. 1986, 78:557-566.
3. 3 by cultured pulmonary alveolar macrophages in sarcoidosis. J.Clin. Invest. 1983, 72:1856-1860.
4. 3. J.Biol. Chem. 1981, 256:7738-7740.
5. Armbrecht H.J., Okuda K., Wongsurawat N., Nemani R.K., Chen M.L., Boltz M.A. Characterization and regulation of the vitamin D hydroxylases. J.Steroid Biochem. Mol. Biol. 1992, 43:1073-1081.
6. Auchus R.J., Lee T.C., Miller W.L. Cytochrome b5 augments the 17,20-lyase activity of human P450cl7 without direct electron transfer. J.Biol. Chem. 1998, 273:3158-3165.
7. 3 25-hydroxylase from rat liver mitochondria. FEBS Lett. 1990, 161:135-138.
8. 3: Gonadotropic r. DNA Cell Biol. 1990, 9:657-665.
9. Cali J.J., Russell D.W. Characterization of human sterol 27-hydroxylase. J.Biol Chem. 1991, 266:7774-7778.
10. Jones G., Strugnell S.A., DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 1998, 78:1193-1231.
11. 3 24-hydroxylase. FEBS Lett. 1991, 278:195-198.
12. 3 24-hydroxylase cDNA. Proc. Natl. Acad. Sci. USA 1993, 90:4543-4547.
13. Chen K.S., DeLuca H.F. Cloning of the human 1 alpha, 25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim. Biophys. Acta 1995, 1263:1-9.
14. Fu G.K., Lin D., Zhang M.Y.H., Bikle D.D., Miller W.L., Portale A.A. Cloning of human 25-hydroxyvitamin D-1α-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol. Endocrinol. 1997, 11:1961-1970.
15. 3 lα-hydroxylase. Biochem. Biophys. Res. Commun. 1997, 239:527-533.
16. St.-Arnaud R., Messerlian S., Moir J.M., Omdahl J.L., Glorieux F.H. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J.Bone Miner. Res. 1997, 12:1552-1559.
17. 3-lα-hydroxylase cDNA. Proc. Natl. Acad. Sci. USA. 1997, 94:12920-12925.
18. 3 lα-hydroxylase and vitamin D synthesis. Science 1997, 277:1827-1830.
19. Fu G.K., Portale A.A., Miller W.L. Complete structure of the human gene for the vitamin D lα-hydroxylase, P450clα. DNA Cell Biol. 1997, 16:1499-1507.
20. 3 lα-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N.Engl. J. Med. 1998, 338:653-661.
21. Yoshida T., Monkawa T., Tenenhouse H.S., Goodyer P., Shinki T., Suda T., Wakino S., Hayashi M., Saruta T. Two novel lα-hydroxylase mutations in French-Canadians with vitamin D dependency rickets type I. Kidney Int. 1998, 54:1437-1443.
22. 3-lα-hydroxylase (CYPlα) gene. Biochim. Biophys. Acta 2000, 1475:109-113.
23. Panda D.K., Al Kawas S., Seldin M.F., Hendy G.N., Goltzman D. 25-Hydroxyvitamin D lalpha-hydroxylase: Structure of the mouse gene, chromosomal assignment, and developmental expression. J.Bone Miner. Res. 2001, 16:46-56.
24. Prader A., Illig R., Heierli E. Eine besondere form des primare vitamin-D-resistenten rachitis mit hypocalcamie und auto-somal-dominanten erbgang: Die hereditare pseudomangelrachitis. Helv. Paediatr. Acta 1961, 16:452-468.
25. Albright F., Butler A.M., Bloomberg E. Rickets resistant to vitamin D therapy. Am. J. Dis. Child. 1937, 54:529-547.
26. Scriver C.R. Vitamin D dependency. Pediatrics 1970, 45:361-363.
27. Stoop J.W., Schraagen M.J., Tiddens H.A. Pseudo vitamin D deficiency rickets. Report of four new cases. Acta Paediatr. Scand. 1967, 56:607-616.
28. Dent C.E., Friedman M., Watson L. Hereditary pseudo-vitamin D deficiency rickets ("hereditare pseudomangelrachitis"). J.Bone Joint Surg. Br. 1968, 50:708-719.
29. Matsuda I., Sugai M., Ohsawa T. Laboratory findings in a child with pseudo-vitamin D deficiency rickets. Helv. Paediatr. Acta 1969, 24:329-336.
30. Fanconi A., Prader A. Hereditary pseudo-vitamin Ddeficiency rickets. Helv. Paediatr. Acta 1969, 24:423-447.
31. Arnaud C., Maijer R., Reade T., Scriver C.R., Whelan D.T. Vitamin D dependency: An inherited postnatal syndrome with secondary hyperparathyroidism. Pediatrics 1970, 46:871-880.
32. Hamilton R., Harrison J., Fraser D., Radde I., Morecki R., Paunier L. The small intestine in vitamin D dependentrickets. Pediatrics 1970, 45:364-373.
33. Delvin E.E., Glorieux F.H., Marie P.J., Pettifor J.M. Vitamin D dependency: Replacement therapy with calcitriol. J.Pediatr. 1981, 99:26-34.
34. Balsan S. Hereditary pseudo-deficiency rickets or vitaminD-dependency type I. Rickets 1991, 155-165. Raven Press, San Diego. F.H. Glorieux (Ed.).
35. Fraser D., Kooh S.W., Scriver C.R. Hyperparathyroidism as the cause of hyperaminoaciduria and phosphaturia in human vitamin D deficiency. Pediatr. Res. 1967, 1:425-435.
36. Fraser D., Kooh S.W., Kind H.P., Holick M.F., Tanaka Y., DeLuca H.F. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to lα,. N.Engl. J. Med. 1973, 289:817-822.
37. Scriver C.R., Reade T.M., DeLuca H.F., Hamstra A.J. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N.Engl. J. Med. 1978, 299:976-979.
38. Wang J.T., Lin C.J., Burridge S.M., Fu G.K., Labuda M., Portale A.A., Miller W.L. Genetics of vitamin D lα-hydroxylase deficiency in 17 families. Am. J. Hum. Genet. 1998, 63:1694-1702.
39. Aarskog D., Aksnes L., Markestad T. Effect of parathyroid hormone on cAMP and 1,25-dihydroxyvitamin D formation and renal handling of phosphate in vitamin D-dependent rickets. Pediatrics 1983, 71:59-63.
40. Mandla S., Jones G., Tenenhouse H.S. Normal 24-hydroxylation of vitamin D metabolites in patients with vitamin D-dependency rickets type I. Structural implications for the vitamin D hydroxylases. J.Clin. Endocrinol. Metab. 1992, 74:814-820.
41. De Braekeleer M., Larochelle J. Population genetics of vitamin D-dependent rickets in northeastern Quebec. Ann. Hum. Genet. 1991, 55:283-290.
42. Labuda M., Morgan K., Glorieux F.H. Mappingautosomal recessive vitamin D dependency type I to chromosomal 12ql4 by linkage analysis. Am. J. Hum. Genet. 1990, 47:28-36.
43. Labuda M., Labuda D., Korab-Laskowska M., Cole D.E., Zietkiewicz E., Weissenbach J., Popowska E., Pronicka E., Root A.W., Glorieux F.H. Linkage disequilibrium analysis in young populations: Pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians. Am. J. Hum. Genet. 1996, 59:633-643.
44. Smith S.J., Rucka A.K., Berry J.L., Davies M., Mylchreest S., Paterson C.R., Heath D.A., Tassabehji M., Read A.P., Mee A.P., Mawer E.B. Novel mutations in the lα-hydroxylase (P450cl) gene in three families with pseudo vitamin D-deficiency rickets resulting in loss of functional enzyme activi. J.Bone Miner. Res. 1999, 14:730-739.
45. 3 lα-hydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifest. J.Clin. Endocrinol. Metab. 1999, 84:4111-4117.
46. Wang X., Zhang M.Y.H., Miller W.L., Portale A.A. Novel gene mutations in patients with lα-hydroxylase deficiency that confer partial enzyme activity in vitro. J.Clin. Endocrinol. Metab. 2002, 87:2424-2430.
47. Poulos T.L., Finzel B.C., Howard A.J. High-resolution crystal structure of cytochrome P450cam. J.Mol. Biol. 1987, 195:687-700.
48. Hasemann C.A., Ravichandran K.G., Peterson J.A., Deisenhofer J. Crystal structure and refinement of cytochrome P450terp at 2.3 A resolution. J.Mol. Biol. 1994, 236:1169-1185.
49. Cupp-Vickery J.R., Poulos T.L. Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nat. Struct. Biol. 1995, 2:144-153.
50. Hasemann C.A., Kurumbail R.G., Boddupalli S.S., Peterson J.A., Deisenhofer J. Structure and function of cytochromes P450: A comparative analysis of three crystal structures. Structure 1995, 3:41-62.
51. Fardella C.E., Hum D.W., Homoki J., Miller W.L. Point mutation of Arg440 to His in cytochrome P450cl7 causes severe 17α-hydroxylase deficiency. J.Clin. Endocrinol. Metab. 1994, 79:160-164.
52. Conte F.A., Grumbach M.M., Ito Y., Fisher C.R., Simpson E.R. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding arom. J.Clin. Endocrinol. Metab. 1994, 78:1287-1292.
53. Auchus R.J., Miller W.L. Molecular modeling of human P450cl7 (17α-hydroxylase/17,20-lyase). Insights into reaction mechanisms and effects of mutations. Mol. Endocrinol. 1999, 13:1169-1182.
54. Sawada N., Sakaki T., Kitanaka S., Kato S., Inouye K. Structure-function analysis of CYP27B1 and CYP27A1. Studies on mutants from patients with vitamin D-dependent rickets type I (VDDR-I) and cerebrotendinous xan. Eur. J. Biochem. 2001, 268:6607-6615.
55. 3 in vitamin D dependency. Pediatr. Res. 1975, 9:593-599.
56. Brooks M.H., Bell N.H., Love L., Stern P.H., Orfei E., Queener S.F., Hamstra A.J., DeLuca H.F. Vita-min-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N.Engl. J. Med. 1978, 298:996-999.
57. Marx S.J., Spiegel A.M., Brown E.M., Gardner D.G., Downs R.W., Attie M., Hamstra A.J., DeLuca H.F. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J.Clin. Endocrinol. Metab. 1978, 47:1303-1310.
58. Malloy P.J., Pike J.W., Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr. Rev. 1999, 20:156-188.
59. Beer S., Tieder M., Kohelet D., Liberman O.A., Vure E., Bar-Joseph G., Gabizon D., Borochowitz Z.U., Varon M., Modai D. Vitamin D resistant rickets with alopecia:A form of end organ resistance to 1,25-dihydroxy vitamin D. Clin. Endocrinol. 1981, 14:395-402.
60. Rosen J.F., Fleishman A.R., Finberg L., Hamstra A., DeLuca H.F. Rickets with alopecia: An inborn error of vitamin D metabolism. J.Pediatr. 1979, 94:729-735.
61. Hochberg Z., Benderli A., Levy J., Vardi P., Weisman Y., Chen T., Feldman D. 1,25-Dihydroxyvitamin D resistance,rickets, and alopecia. Am. J. Med. 1984, 77:805-811.
62. Hochberg Z., Gilhar A., Haim S., Friedman-Birnbaum R., Levy J., Benderly A. Calcitriol-resistant rickets with alopecia. Arch. Dermatol. 1985, 121:646-647.
63. Marx S.J., Bliziotes M.M., Nanes M. Analysis of therelation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin. Endocrinol (Oxford) 1986, 25:373-381.
64. Liberman U.A., Halabe A., Samuel R., Kauli R., Edelstein S., Weisman Y., Papapoulos S.E., Clemens T.L., Fraher L.J., O'Riordan J.L.H. End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet 1980, 1:504-507.
65. Yagi H., Ozono K., Miyake H., Nagashima K., Kuroume T., Pike J.W. A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant rick. J.Clin. Endocrinol. Metab. 1993, 76:509-512.
66. Hirst M.A., Hochman H.I., Feldman D. Vitamin D resistance and alopecia: A kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid. J.Clin. Endocrinol. Metab. 1985, 60:490-495.
67. 3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia. Pediatrics 1987, 80:97-101.
68. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., Dominguez C.E., Jurutka P.W. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J.Bone Miner. Res. 1998, 13:325-349.
69. 3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissoc. J.Biol. Chem. 1997, 272:14592-14599.
70. Masuyama H., Brownfield C.M., St.-Arnaud R., MacDonald P.N. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol. Endocrinol. 1997, 11:1507-1517.
71. Thompson P.D., Remus L.S., Hsieh J.C., Jurutka P.W., Whitfield G.K., Galligan M.A., Encinas D.C., Haussler C.A., Haussler M.R. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts. J.Mol. Endocrinol. 2001, 27:211-227.
72. Nakajima S., Hsieh J.C., MacDonald P.N., Galligan M.A., Haussler C.A., Whitfield G.K., Haussler M.R. The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vita. Mol. Endocrinol. 1994, 8:159-172.
73. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Naar A.M., Erdjument-Bromage H., Tempst P., Freedman L.P. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999, 398:824-828.
74. Eil C., Liberman U.A., Rosen J.F., Marx S.J. A cellular defect in hereditary vitamin-D dependent rickets type II:Defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts. N.Engl. J. Med. 1981, 304:1588-1591.
75. 3. J.Clin. Endocrinol. Metab. 1982, 55:1020-1022.
76. Balsan S., Garabedian M., Liberman U.A., Eil C., Bourdeau A., Guillozo H., Grimberg R., Le Deunff M.J., Lieberherr M., Guimbaud P., Broyer M., Marx S.J. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: Two different clinical courses with two different cellular defects. J.Clin. Endocrinol. Metab. 1983, 57:803-811.
77. 3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vita-min-D-dependent rickets, t. J.Clin. Endocrinol. Metab. 1983, 56:824-830.
78. Liberman U.A., Eil C., Marx S.J. Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts. J.Clin. Invest. 1983, 71:192-200.
79. Chen T.L., Hirst M.A., Cone C.M., Hochberg T., Tietze H.U., Feldman D. 1,25-Dihydroxytiamin D resistance,rickets, and alopecia: Analysis of receptors and bioresponse in cultured fibroblasts from patients and parents. J.Clin. Endocrinol. Metab. 1984, 59:383-388.
80. Liberman U.A., Eil C., Hoist P., Rosen J.F., Marx S.J. Hereditary resistance to 1,25-dihydroxyvitamin D: Defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone. J.Clin. Endocrinol. Metab. 1983, 57:958-962.
81. Griffin J.E., Zerwekh J.E. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positiv. J.Clin. Invest. 1983, 72:1190-1199.
82. Liberman U.A., Eil C., Marx S.J. Receptor-positive hereditary resistance to 1,25-dihydroxyvitamin D: Chromatography of hormone-receptor complexes on deoxyribonucleic acid-cellulose shows two. J.Clin. Endocrinol. Metab. 1986, 62:122-126.
83. Dokoh S., Haussler M.R., Pike J.W. Development of a radioligand immunoassay for 1,25-dihydroxycholecalciferol receptors utilizing monoclonal antibody. Biochem. J. 1984, 221:129-136.
84. 3 receptor. Proc. Natl. Acad. Sci. USA 1982, 79:7719-7723.
85. 3 receptors. Science 1984, 224:879-881.
86. 3. Interaction and effects of binding on receptor function. J.Biol. Chem. 1984, 259:1167-1173.
87. 3 in cultured skin fibroblas. J.Clin. Invest. 1985, 75:954-960.
88. Malloy P.J., Hochberg Z., Pike J.W., Feldman D. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II. J.Clin. Endocrinol. Metab. 1989, 68:263-269.
89. McDonnell D.P., Mangelsdorf D.J., Wesley Pike J., Haussler M.R., O'Malley B.W. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 1987, 235:1214-1217.
90. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., Pike J.W., Shine J., O'Malley B.W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA 1988, 85:3294-3298.
91. 3 receptor gene (VDR) are colocalized on human chromosome arm 12q and rat chromosom. Genomics 1991, 11:168-173.
92. Hughes M.R., Malloy P.J., Kieback D.G., Kesterson R.A., Pike J.W., Feldman D., O'Malley B.W. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 1988, 242:1702-1705.
93. 3 in humans are transcriptionally inactive in vitro. J.Biol. Chem. 1989, 264:20230-20234.
94. 3-resistant rickets in three families. Proc. Natl. Acad. Sci. USA 1989, 86:9783-9787.
95. 3 resistant rickets in seven related families. J.Clin. Invest. 1990, 86:2071-2079.
96. Malloy P.J., Hughes M.R., Pike J.W., Feldman D. Vitamin D receptor mutations and hereditary 1,25-dihydroxyvitamin D resistant rickets. Vitamin D: Gene Regulation, Structure-Function Analysis, and Clinical Application. Eighth Workshop on Vitamin D 1991, 116-124. de Gruyter, New York. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
97. Thompson E., Kristjansson K., Hughes M. Molecular scanning methods for mutation detection: Application to the 1,25-dihydroxyvitamin D receptor. Vitamin D: Gene Regulation, Structure-Function Analysis, and Clinical Application. Eighth Workshop on Vitamin D 1991, 6. de Gruyter, New York. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
98. Rut A.R., Hewison M., Rowe P., Hughes M., Grant D., O'Riordan J.L.H. A novel mutation in the steroid binding region of the vitamin D receptor (VDR) gene in hereditary vitamin D resistant rickets (HVDRR). Vitamin D: Gene Regulation, Structure-Function Analysis, and Clinical Application. Eighth Workshop on Vitamin D 1991, 94-95. de Gruyter, New York. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
99. Wiese R.J., Goto H., Prahl J.M., Marx S.J., Thomas M., al-Aqeel A., DeLuca H.F. Vitamin D-dependency rickets type II: Truncated vitamin D receptor in three kindreds. Mol. Cell. Endocrinol. 1993, 90:197-201.
100. 3. J.Clin. Invest. 1993, 92:12-16.
101. Malloy P.J., Eccleshall T.R., Gross C., Van Maldergem L., Bouillon R., Feldman D. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hypore. J.Clin. Invest. 1997, 99:297-304.
102. 3: Point mutations confer reduced transactivation in response to ligand and im. Mol. Endocrinol. 1996, 10:1617-1631.
103. Cockerill F.J., Hawa N.S., Yousaf N., Hewison M., O'Riordan J.L., Farrow S.M. Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets. J.Clin. Endocrinol. Metab. 1997, 82:3156-3160.
104. Malloy P.J., Zhu W., Zhao X.Y., Pehling G.B., Feldman D. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets. Mol. Genet. Metab. 2001, 73:138-148.
105. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991, 352:497-505.
106. Rastinejad F., Perlmann T., Evans R.M., Sigler P.B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 1995, 375:203-211.
107. Rut A.R., Hewison M., Kristjansson K., Luisi B., Hughes M.R., O'Riordan J.L. Two mutations causing vitamin D resistant rickets: Modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures. Clin. Endocrinol. (Oxford) 1994, 41:581-590.
108. 3. Mol. Endocrinol. 1990, 4:623-631.
109. Saijo T., Ito M., Takeda E., Huq A.H., Naito E., Yokota I., Sone T., Pike J.W., Kuroda Y. A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: Utility of single-strand conformation po. Am. J. Hum. Genet. 1991, 49:668-673.
110. Malloy P.J., Weisman Y., Feldman D. Hereditary lα,25-dihydroxyvitamin D-resistant rickets resulting from a mutation in the vitamin D receptor deoxyribonucleic acid-binding domain. J.Clin. Endocrinol. Metab. 1994, 78:313-316.
111. Hawa N.S., Cockerill F.J., Vadher S., Hewison M., Rut A.R., Pike J.W., O'Riordan J.L., Farrow S.M. Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping. Clin. Endocrinol. (Oxford) 1996, 45:85-92.
112. Lin N.U., Malloy P.J., Sakati N., al-Ashwal A., Feldman D. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets. J.Clin. Endocrinol. Metab. 1996, 81:2564-2569.
113. 3-resistant rickets. J.Clin. Endocrinol. Metab. 1997, 82:3892-3894.
114. Zhu W., Malloy P.J., Delvin E., Chabot G., Feldman D. Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor. J.Bone Miner. Res. 1998, 13:259-264.
115. Malloy P.J., Xu R., Peng L., Clark P.A., Feldman D. A novel mutation in helix 12 of the VDR impairs coactivator interaction and causes 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Mol. Endocrinol. 2002, 16:2538-2546.
116. Malloy P.J., Zhu W., Bouillon R., Feldman D. A novel nonsense mutation in the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets. Mol. Genet. Metab. 2002, 11:314-318.
117. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell 2000, 5:173-179.
118. Hewison M., Rut A.R., Kristjansson K., Walker R.E., Dillon M.J., Hughes M.R., O'Riordan J.L. Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene. Clin. Endocrinol. (Oxford) 1993, 39:663-670.
119. Zerwekh J.E., Glass K., Jowsey J., Pak C.Y.C. A unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J.Clin. Endocrinol. Metab. 1979, 49:171-175.
120. 3. J.Clin. Endocrinol. Metab. 1982, 55:1020-1022.
121. Balsan S., Garabedian M., Larchet M., Groski A.M., Cournot G., Tau C., Bourdeau A., Silve C., Ricour C. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J.Clin. Invest. 1986, 77:1661-1667.
122. Hochberg Z., Tiosano D., Even L. Calcium therapy for calcitriol-resistant rickets. J.Pediatr. 1992, 121:803-808.
123. Kudoh T., Kumagai T., Uetsuji N., Tsugawa S., Oyanagi K., Chiba Y., Minami R., Nakao T. Vitamin D dependent rickets: Decreased sensitivity to 1,25-dihydroxyvitamin D. Eur. J. Pediatr. 1981, 137:307-311.
124. Castells S., Greig F., Fusi M.A., Finberg L., Yasumura S., Liberman U.A., Eil C., Marx S.J. Severely deficient binding of 1,25-dihydroxyvitamin D to its receptors in a patient responsive to high doses of this hormone. J.Clin. Endocrinol. Metab. 1986, 63:252-256.
125. Kruse K., Feldmann E. Healing of rickets during vitamin D therapy despite defective vitamin D receptors in two siblings with vitamin D-dependent rickets type II. J.Pediatr. 1995, 126:145-148.